aimed analytics
aimed analytics provides an AI-powered SaaS platform for fast, no-code biomedical omics data analysis, enabling researchers to transform raw data into actionable insights in minutes.
About
aimed analytics is a German biotech company developing a self-service SaaS platform that empowers pharmaceutical companies, biotech firms, and biomedical researchers to analyze complex omics datasets (including transcriptomics, epigenomics, proteomics, and multiomics) without coding or extensive bioinformatics expertise. Their AI-driven, modular platform provides rapid, interactive analysis and visualization tools tailored for professionals in pharma, biotech, and academic research, streamlining workflows from raw data upload to publication-ready results in minutes rather than weeks. The platform is built with strong emphasis on data security, European data hosting, and compliance with EU data protection legislation. aimed analytics is committed to democratizing access to advanced biomedical data analytics, accelerating drug discovery, biomarker identification, and the development of personalized and precision medicine.
Products & Services
- AI-powered SaaS platform for omics data analysis
- No-code biomedical analytics tools
- Interactive data visualization and reporting
- Automated workflows for transcriptomics, epigenomics, proteomics, and multiomics data
- Customized analysis modules (e.g., pathway enrichment, differential expression, clustering, biomarker discovery, cell-type annotation, etc.)
- Data security and compliance services
- Expert support for data preprocessing and analysis
- Professional consulting for pharma and biotech research projects
- Self-service demo and trial access
- Customer support through email, chat, and phone
Use Cases & Case Studies
- Accelerating pathway validation in tumor-associated macrophage research (SHP-2 pathway in oncology)
- Validating differential expression in breast cancer fibroblasts using no-code analysis and volcano plots
- Replicating early transcriptional changes in Alzheimer’s research via automated transcriptomics workflows
- Use in large published studies on COVID-19, COPD, leukemia, and other disease research
- Expertise demonstrated in 29 peer-reviewed publications, including use in Alzheimer’s, cancer, and immunology studies
Partnerships & Collaborations
- TME Pharma (AI-driven drug discovery collaboration)
- Partnerships with proMetis Consulting GmbH and Pi-Holding GmbH (investment/strategic partners)
- Acquisition of ValueData GmbH
- Collaboration and networking with major pharma companies such as Novo Nordisk (event interest)
- Academic collaborations with DZNE and University of Bonn
Awards & Recognition
- Best BioTech Solutions Company 2024—Europe at the German Business Awards (2024)
- Participation as a top 6 startup at HEALTH+ DEMO DAY 2023, North Rhine-Westphalia
- EXIST Founder Scholarship recipient
Contact Information
Certifications & Compliance
- EU data protection compliance (EU-Legislation, GDPR)
- Data stored on European servers